Professional Documents
Culture Documents
LABORATORY RESULTS –
ANALYTICAL & NON-
ANALYTICAL
1
Bridging
11/27/2023 2
FACTORS THAT MAY INFLUENCE LABORATORY RESULTS
Classified into:
Pre-analytical factors
Analytical factors
Post-analytical factors
11/27/2023 3
Please indicate possible pre-analytical factor that might be
responsible for each of the following pattern of results
(N=normal, ↑=high, ↓=low, - = not done)
11/27/2023 4
Pre-analytical
Non-modifiable biological factors
■ Biologic rhythms
■ Age
■ Sex
■ Physiological changes during pregnancy
11/27/2023 5
■ These factors may be controlled for, e.g. by selecting the most
appropriate time in the day, month or year for a test, or may be taken
into consideration in the interpretation of results
ALP and Age
■ Upper reference limit ↑↑ increased during puberty - time of maximum
bone remodeling.
■ Levels fall to a new upper limit through younger adult life, rise again in
females around the time of perimenopause, largely reflecting an increase
in bone turnover at that time.
■ Marked increases in serum ALP may also occur in women in late
pregnancy (due to production of ALP by the placenta), and during other
times such as in the weeks after healing of a fracture.
11/27/2023 6
Biological rhythms
■ Hormone production (e.g. cortisol, testosterone) follow a circadian (24
hour) rhythm
■ Tests are recommended at specific times of the day, e.g. testosterone
should be sampled between 7 am – 10 am.
- Peak testosterone levels usually occur in the early morning;
■ serum cortisol should preferably be sampled in the early morning as
there is marked diurnal variation
11/27/2023 7
Pregnancy
■ Alterations in many laboratory parameters, such as blood volume,
liver and renal function and hormone levels
■ Alterations in binding proteins, can affect assays differently, e.g.
free hormone levels can be assay dependent
11/27/2023 8
11/27/2023 9
Modifiable biological factors
Individual variations
■ A patient’s diet, health status and lifestyle factors can all have
a pre-analytical influence on laboratory parameters.
■ Diet and nutritional status
• Creatinine; a recent meal with high meat content can have a
significant influence on serum creatinine
• Sustained low caloric intake and starvation can result in numerous
changes to laboratory parameters such as glucose, thyroid function,
electrolytes, liver function, renal function and lipids.
11/27/2023 10
■ Malnutrition
■ Dehydration
■ Caffeine
■ Tobacco smoking
■ Exercise
■ Medicines
■ Alcohol
11/27/2023 11
Chronic effects of alcohol consumption on laboratory investigations
include:
Elevated gamma glutamyl transferase (GGT) and mean cell volume
(MCV) which are commonly used to test for excessive alcohol
consumption
Elevated aspartate aminotransferase (AST), alanine aminotransferase
(ALT) and AST/ALT ratio
Elevated triglyceride levels
Elevated uric acid and ferritin levels due to fatty liver and alcoholic
hepatitis
Elevated creatine kinase due to alcoholic myopathy
Haematological abnormalities, e.g. anaemia and thrombocytopenia
11/27/2023 12
11/27/2023 13
11/27/2023 14
The Pre-Analytical process
■ Patient Identification
■ Sampling Technique
■ Specimen Transport
■ Specimen Processing
11/27/2023 15
Test Collection
■ Timing of Collection
11/27/2023 16
Sample collection
a) Posture
- Based on Starlings law of capillary exchange:
Haemodynamic adaptation to postural change (e.g. lying to
sitting and vice versa).
- postural changes will affect proteins & protein bound
analytes e.g. Ca²˖, Fe²˖, Cholesterol, Triglycerides, etc.
b) Prolonged application of tourniquet - ↑ Protein & protein
bound analytes
c) IV solutions - e.g. NaCl drip: ↑Na & Cl (other analytes ±↓)
d) Hemolysis
- narrow bore needle, tight tourniquet, sample clotting
during
collection→↑K, Mg, PO3, AST, LDH
11/27/2023 17
e) Sample tubes
- e.g. K-EDTA will influence the following analytes: K(↑),
Ca(↓),
Mg(↓), Zn(↓), ALP(↓)
f) Sequence of sample collection (multiple tubes)
- tubes without preservatives 1st
g) Sample volume & mixing where necessary
h) Type of sample
- e.g. arterial vs venous blood: PCO2, PO2
i) Mislabeling of sample tubes
j) Exercise
- e.g. ↑ CK, AST, LDH etc.
k) Sex - e.g. ↑ PSA
11/27/2023 18
Sample collection
11/27/2023 19
11/27/2023 20
11/27/2023 21
Sample transportation
a) Improper preservation e.g. ice or not
e.g. ACTH, ammonia, lactate, etc.
b) Delayed transportation to the lab
e.g. K, AST, ALT etc.
11/27/2023 22
Problem Cause(s) Aff ects
overnight storage
Increases potassium, &
Delay in processing
delay in transit phosphate
Increases potassium
storage of samples
Incorrect storage
overnight in fridge
Decreases bicarbonate
Increased potassium
Contamination of red/
yellow top tubes with
Incorrect sample tube
blood containing EDTA Decreased calcium, alkaline
(from purple top tube) phosphatase, iron,
magnesium
Decreases sodium
Lipaemia (fatty Sample taken shortly
sample) aft er fatty meal
Aff ects other analytes if
severe
11/27/2023 23
Analytical Factors
■ Calibration
■ Internal quality control
■ Assay (method) characteristics
■ Reagents integrity & preparation
■ Instrument maintenance
■ Dilution and pipetting techniques
11/27/2023 24
Analytical Factors
■ Accuracy
■ Imprecision
■ Sensitivity & specificity
■ Linearity
11/27/2023 25
Post-Analytical Factors
11/27/2023 26
ERRORS IN LABORATORY
MEDICINE :
DETECTION & PREVENTION
11/27/2023 27
Definitions
11/27/2023 28
Definitions
■ Mistakes, blunders, defects, outliers, unacceptable results and quality
failure
■ - Have negative connotations of blame, individual failure and culpability
The risk of adverse events and inappropriate care due to laboratory errors
ranges from 2.7% to 12%,
In a larger percentage of cases (24.4% to 30%), the laboratory error
translates into a patient care problem
■ - further inappropriate investigations
■ - more invasive testing and additional consultations
Creates discomfort and incurs higher costs for both patients and the
health-care system
Impact on patient outcome (Goldschmidt)
11/27/2023 38
Processes to address errors
1. Identify high-risk processes where the potential error could
lead to a safety risk for patients
2. Identifying actual incidents associated with deviations from
standard requirements
3. Estimating and evaluating the associated risks to patient safety
4. Controlling these risks and
5. monitoring the effectiveness of the control undertaken.
Processes to reduce errors in laboratory medicine
Several initiatives
■ World Alliance for Patient Safety – critical values reporting
■ Joint Commission 2008 National Patient Safety Goals for
Laboratories – communication among care givers
■ Working Group on ‘Laboratory errors and patient Safety’-
‘Model of quality indicators’
- 25 quality indicators: 16 pre-analytic, 3 analytic and 6 for
the post-analytic phase
Cheese model
The presence of holes in any one defensive layer does not normally cause adverse events.
Usually this happens only when the holes in many layers line up to permit a trajectory of
accident opportunity
11/27/2023 44
SPECIMEN REJECTION CRITERIA
Specimens to which the following conditions apply will be rejected, returned to the
originating site or specimen processing delayed. The physician office will be notified.
11/27/2023 45
■THANK YOU
11/27/2023 46